Updated:
Celeridem Capital Management
Celeridem Capital Management is a US-based investment company headquartered in Tampa. It pursues a Venture Capital strategy. The firm has 4 staff, including 4...
Celeridem Capital Management
Celeridem Capital Management is a US-based investment company headquartered in Tampa. It pursues a Venture Capital strategy. The firm has 4 staff, including 4 investment professionals.
General information
Firm type
Generalist
Year founded
2016
Location
Region
North America
Country
United States
City
Tampa
Corporate office
Tampa, FL, United States
Principals
Shivan Govindan
Managing Member and Chief Investment Officer
Jeff Hunt
Co-founder and Managing Member
Michael J. Price
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at Celeridem Capital Management?
Shivan Govindan serves as Managing Member and Chief Investment Officer, leading investment decisions at the firm. Co-founder Jeff Hunt is also a Managing Member and maintains a concurrent role as Senior Managing Director at Skyway Capital Markets. Michael J. Price, formerly Vice Chairman at Evercore and Co-Head of TMT at Lazard, serves as Managing Director and contributes to deal evaluation and sourcing.
How does Celeridem source proprietary deal flow?
Celeridem sources deal flow through its principals' deep embeddedness in financial services advisory and investment banking. Jeff Hunt's concurrent role at Skyway Capital Markets provides visibility into middle-market financial technology companies seeking capital, while Michael J. Price's background at Evercore and Lazard extends the network into large-cap financial institution relationships. This advisory-plus-principal structure surfaces early-stage opportunities through transaction workflows rather than traditional venture-scout networks.
Does Celeridem participate in fund commitments or only direct deals?
Available public information indicates Celeridem focuses on direct investments in early-stage companies rather than fund commitments. The firm's known portfolio consists of direct equity positions in ventures such as Symbiont.io, deployed alongside co-investors that share a financial technology specialization.
What investment stages does Celeridem typically target?
Celeridem targets early-stage companies, as confirmed by Altss research records. The firm's positioning in venture-stage rounds for enterprise financial technology and blockchain infrastructure aligns with the backgrounds of its principals, who bring strategic advisory capabilities relevant to companies navigating initial institutional capital raises.
Which sectors does Celeridem explicitly focus on?
The firm concentrates on financial technology and enterprise blockchain infrastructure. Its known portfolio includes Symbiont.io, an enterprise blockchain platform, and its co-investor network — Atlantic Merchant Capital Investors and SenaHill Partners — both specialize in financial technology ventures.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: